A glimpse of hope: cardiac surgery in low- and middle-income countries (LMICs)

Peter Zilla1, R Morton Bolman2, Percy Boateng3

  • 1Christian Barnard Department for Cardiothoracic Surgery, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.

Insights

Millions in low- and middle-income countries (LMICs) lack access to life-saving cardiac surgery, with rheumatic heart disease (RHD) being a major cause. Expanding surgical services in LMICs faces significant challenges despite growing needs.

Area of Science:

  • Cardiovascular Surgery
  • Global Health Equity
  • Public Health Policy

Background:

  • The majority of the global population resides in low- and middle-income countries (LMICs), yet cardiac surgical needs in these regions are largely unmet.
  • While high-income countries (HICs) see declining cardiac surgery demands, LMICs face a critical deficit in access to essential heart operations.

Purpose of the Study:

  • To highlight the disparity in cardiac surgical access between HICs and LMICs.
  • To underscore the significant burden of Rheumatic Heart Disease (RHD) as a primary driver of cardiac surgical needs in LMICs, particularly among younger populations.
  • To identify the challenges hindering the expansion of cardiac surgical services in LMICs.

Main Methods:

  • Comparative analysis of cardiac surgical needs and capacities in HICs versus LMICs.
  • Examination of the epidemiological drivers of cardiac surgical demand in different income settings, focusing on RHD prevalence.
  • Assessment of existing cardiac surgical infrastructure and service delivery models in LMICs.

Main Results:

  • Rheumatic heart disease (RHD) is the predominant indication for cardiac surgery in young patients in low- and middle-income countries, significantly outweighing other conditions.
  • Cardiac surgical capacity in LMICs is severely limited (0.5-481 operations/million population) compared to HICs (>1,200 operations/million).
  • Despite recent efforts to establish local services in low-income countries (LICs), coverage remains below 2% of the population's needs, while middle-income countries (MICs) face growing demand and access gaps.

Conclusions:

  • Urgent global health strategies are required to address the critical unmet need for cardiac surgery in LMICs.
  • Overcoming challenges such as limited surgical skills, valve availability, and socioeconomic barriers is crucial for improving cardiac care access in LMICs.
  • Addressing the specific needs of younger RHD patients and bridging the gap between public and private healthcare in MICs are essential for equitable cardiac surgical care.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
194
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
219
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
277
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
451
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
330
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
818